Loading chart...



The current price of PNT is 0 USD — it has increased 0
POINT Biopharma Global Inc is a clinical-stage pharmaceutical company focused on the development and commercialization of radioligand therapies for the treatment of cancer. Its product pipeline includes PNT2002; PNT2004; PNT2003; PNT2001 and others.
Wall Street analysts forecast PNT stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for PNT is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
POINT Biopharma Global Inc. revenue for the last quarter amounts to NaN USD, decreased
POINT Biopharma Global Inc.. EPS for the last quarter amounts to USD, decreased
POINT Biopharma Global Inc. (PNT) has 129 emplpoyees as of April 04 2026.
Today PNT has the market capitalization of 1.33B USD.